Indonesia’s recovery has been delayed by renewed restrictions and uncertainty as the Delta COVID‑19 variant spread rapidly. Growth in 2021 is projected to be relatively modest at 3.3%, but will rebound in 2022 and 2023 to above 5% as the normalising health situation allows consumer demand and investor confidence to return. Inflation expectations remain well anchored and the pass-through of higher global prices into consumer prices is expected to be limited. Delays in securing vaccines and vaccinating the eligible population would risk further health crises, slowing the recovery and placing policy under stress.
The government’s plan to progressively return the budget deficit to within its 3% of GDP ceiling is appropriate if Indonesia stays on track to vaccinate the eligible population by early 2022 and can fully lift health restrictions. If the recovery is delayed, additional fiscal support would limit further social and economic damage. Following the crisis, investing more in skills, infrastructure and social protection would enable a more sustained and inclusive recovery. This can be financed by boosting revenues while reallocating spending from the remaining poorly-targeted subsidies. Improving institutional integrity, including by protecting Bank Indonesia’s independence, will help deepen domestic financial markets and better protect Indonesia from shifts in global financial market sentiment.